The U.S. Food and Drug Administration is talking when they should be listening
On May 9-10, 2017, the U.S. Food and Drug Administration (FDA) held a workshop titled “Training health care providers on pain management and safe use of opioid analgesics — exploring the path forward.” I attended the workshop in person to offer comments on behalf of chronic pain patients. A summary of my observations at the time was published by the now-defunct Pain News Network. The following extended extract is from …
The U.S. Food and Drug Administration is talking when they should be listening












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)






![Why loving organizations are the secret to ending burnout in medicine [PODCAST]](https://kevinmd.com/wp-content/uploads/603e9e41-66d6-47f3-a831-f1f9c17489b3-190x100.jpeg)
